International Clinical Trial: CIC101-02-LT is a Long-term Follow-up Study of Subjects Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892937) titled 'CIC101-02-LT is a Long-term Follow-up Study of Subjects Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101' on Oct. 19.

Study Type: Observational

Primary Sponsor: CellinCells

Condition: Atrophic Scar

Recruitment Status: Not recruiting

Date of First Enrollment: March 31, 2027

Target Sample Size: 31

To know more, visit https://clinicaltrials.gov/study/NCT07892937

Disclaimer: Curated by HT Syndication....